In agreement with these findings, knockout of PAK1 in the intestinal tumour model of APC∆14/+ mice inhibited intestinal tumour initiation and progression and increased the numbers of both B and T cells in the spleen, although no significant difference was observed in the numbers of circulating neutrophils and lymphocytes. This evidence concerns the gene PAK1 and intestinal neoplasm.